MARKET

BTTX

BTTX

BETTER THERAPEUTICS INC
NASDAQ
1.760
+0.060
+3.53%
After Hours: 1.760 0 0.00% 17:10 09/30 EDT
OPEN
1.680
PREV CLOSE
1.700
HIGH
1.790
LOW
1.680
VOLUME
42.33K
TURNOVER
0
52 WEEK HIGH
29.40
52 WEEK LOW
0.9120
MARKET CAP
41.79M
P/E (TTM)
-0.6900
1D
5D
1M
3M
1Y
5Y
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
Benzinga · 09/22 13:44
Better Therapeutics files for FDA approval of new type of digital therapy for diabetes
Better Therapeutics (NASDAQ:BTTX) <a href="https://seek...
Seekingalpha · 09/22 13:17
Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 09/20 11:42
Insider Buy: Better Therapeutics
Insider Buy: Better Therapeutics
MT Newswires · 09/19 07:36
Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Nasdaq 100 dropped by more than 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 09/16 13:14
Better Therapeutics to Participate in Three Upcoming Investor Conferences
SAN FRANCISCO, September 07, 2022--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announce...
Business Wire · 09/07 11:30
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.
Benzinga · 08/23 10:11
AXSM, NHWK and VERU are among pre market gainers
SaverOne (SVRE) +63%. XORTX Therapeutics (<a href="https://seekingalp...
Seekingalpha · 08/22 12:20
More
About BTTX
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company. The Company is engaged in developing a novel form of cognitive-behavioral therapy to address the root causes of cardiometabolic diseases. The Company's Nutritional Cognitive Behavioral Therapy (Nutritional CBT) is a novel form of behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases. It targets the cognitive structures, behavioral routines, emotional patterns, and coping skills that underlie culturally specific eating behaviors. Its clinical development pipeline includes BT-001, BT-002, BT-003, and BT-004. The BT-001 is an investigational PDT platform that is designed to use digitally delivered Nutritional CBT to treat type 2 diabetes. The Company's platform consists of three integrated components, behavioral therapy, treatment plans, and personalization. Its behavioral therapy consists of lessons, skill-building modules, and a mechanism for goal setting.

Webull offers kinds of Better Therapeutics Inc stock information, including NASDAQ:BTTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BTTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BTTX stock methods without spending real money on the virtual paper trading platform.